Company Overview and News

 
D-Street Buzz: Nifty IT, pharma outperforms led by KPIT Tech, Dr Reddy#39;s Labs; auto drags

16h moneycontrol
The Indian benchmark indices are trading in the red this Monday morning with the Nifty50 down 25 points, trading at 10,446 while the Sensex shed 47 points at 34,685.
IOC BAJAJ-AUTO 500408 500325 524816 RELIANCE TCHQY 532218 532977 532755 CADILAHC 535789 505200 SOUTHBANK 532343 532321 NATCOPHARM PINCON RIGD GAILF EICHERMOT RLNIY ECQRY 538771 TVSMOTOR IDKQY 530965 CDLYY TECHM IBULHSGFIN GAILY TATAELXSI DCMSHRIRAM 523367

 
New age takeover: Debit card PoS transactions of Airtel, Paytm, Fino Payments banks beat those of mid-sized PSBs!

23h financialexpress
The volume of point-of-sale (POS)-based transactions reported by debit card users of three payments banks—Airtel Payments Bank, Fino Payments Bank and Paytm Payments Bank — is now higher than those made by debit card holders of some mid-sized public sector banks (PSBs), data from the Reserve Bank of India (RBI) showed.
532121 UDBKL UBLA UBLS TCHQY DENABANK 532755 TECHM 532401 VIJAYABANK

2
Government workplaces lag in setting up anti-sexual harassment mechanisms

2018-10-11 livemint
Mumbai: As mandatory reporting of sexual harassment cases at the workplace reaches its fourth year, there seems to be a stark difference between the mechanism instituted in public sector undertakings (PSUs) and their private peers. Data shows that the number of reported instances of sexual harassment at the workplace was higher in private sector companies compared with state-owned ones during financial year 2018.
AXB IBN INFY TCHQY 532755 533278 532215 NTPZY TECHM AXBKY AXBA WIT ICICIBANK AXISBANK 532174 CLNDY COALINDIA

 
Eventual sale of ILFS imminent?

2018-10-09 moneycontrol
The new government appointed board of debt-ridden Infrastructure Leasing and Financial Services (IL&FS) has swung into action and fast. Just a few days ago, the board met for the first time in a marathon five hour meeting to discuss the road forward.
YESBANK TCHQY 532648 YYBKY 532755 TECHM

 
IL&FS faces impairments of ₹ 15,000 crore in loans, equity

2018-10-08 livemint
Mumbai: Crisis-hit Infrastructure Leasing and Financial Services (IL&FS) may require impairments of around ₹ 15,000 crore in loans and equity in its subsidiaries, said a report by Singapore-based REDD Intelligence. According to the report, IL&FS reported consolidated debt of ₹ 91,080 crore.
ICICIBANK KMBKY 532174 IBN KOTAKBANK TCHQY 500247 532755 TECHM

 
Tech Mahindra expects 30-40% growth in cyber security biz

2018-10-07 moneycontrol
IT company Tech Mahindra expects its cyber security business to grow in the range of 30-40 percent, at least for the next three years, according to a senior company official.
TCHQY 532755 TECHM

 
Tech Mahindra expects 30-40 pct growth in cyber security business

2018-10-07 financialexpress
IT company Tech Mahindra expects its cyber security business to grow in the range of 30-40 per cent, at least for the next three years, according to a senior company official.
TCHQY 532755 TECHM

 
IT fund investors cheer 47% average returns in last one year amid equity market meltdown

2018-10-05 moneycontrol
At a time when almost all the mutual fund categories are bleeding with negative returns, investors of information technology funds have a reason to cheer.
532540 TCHQY TCS TTNQY 532755 TECHM

 
348 arms make IL&FS resolution complex: Uday Kotak

2018-10-05 freepressjournal.in
Mumbai: IL&FS group chairman Uday Kotak on Thursday hinted that the crisis at the infra lending and engineering conglomerate is much more complex than earlier thought as the number of its subsidiaries and associates have more than doubled to 348,most of which have negative net worth.
KMBKY KOTAKBANK TCHQY 500247 532755 TECHM

 
India, Russia to sign economic agreements, discuss rupee-rouble payment mechanism

2018-10-04 thehindubusinessline
Russian President Vladimir Putin waves upon his arrival at the Palam Air Force Station in New Delhi on Thursday - PTI
500325 RELIANCE RIGD TCHQY 532755 TECHM RLNIY

 
ILFS Group companies count stands at a whopping 348!

2018-10-04 moneycontrol
After a board meeting which lasted over five hours, the complexities in the debt-laden Infrastructure Leasing and Financial Services (IL&FS) are rearing its head after it came to light that the Group now has 348 subsidiaries as against earlier publicly disclosed figure of 169.
TCHQY 532755 TECHM

 
IL&FS appoints Vineet Nayyar as managing director

2018-10-04 livemint
Bengaluru/Mumbai: India’s Infrastructure Leasing & Financial Services (IL&FS), a debt-burdened infrastructure financing and construction company, has appointed Vineet Nayyar as its managing director, the company’s new Non-Executive Chairman Uday Kotak told reporters on Thursday.
KMBKY KOTAKBANK TCHQY 500247 532755 TECHM

 
IL&FS appoints Vineet Nayyar as managing director

2018-10-04 reuters
NEW DELHI, Oct 4 (Reuters) - India’s Infrastructure Leasing & Financial Services (IL&FS), a debt-burdened infrastructure financing and construction company, has appointed Vineet Nayyar as its managing director, the company’s new Non-Executive Chairman Uday Kotak told reporters on Thursday.
KMBKY KOTAKBANK TCHQY 500247 532755 TECHM

 
IL&FS new board’s 1st meeting: Tech Mahindra’s Vineet Nayyar appointed VC and MD of infra financing company

2018-10-04 financialexpress
The new board of IL&FS, chaired by top banker Uday Kotak, met on Thursday for the first time, in which it was decided that the Vineet Nayyar will be the Vice Chairman and the Managing Director of the company. The newly-constituted seven-member board took a comprehensive view of the problems in the company and decided that the necessary steps will be taken to address the issues of the company.
TCHQY 532755 TECHM

Related Articles

ALIM: Alimera Sciences Analysis and Research Report

2018-10-01 - Asif

Overview The following discussion and analysis should be read in conjunction with its unaudited interim condensed consolidated financial statements and the related notes that appear elsewhere in this quarterly report on Form 10-Q. This discussion contains forward-looking statements reflecting its current expectations that involve risks and uncertainties. Actual results may differ materially from those discussed in these forward-looking statements due to a number of factors, including those set forth in the section entitled “Risk Factors” in its most recent annual report on Form 10-K. For further information regarding forward-looking statements, please refer to the “Special Note Regarding Forward-Looking Statements and Projections” immediately after the index to this quarterly report on Form 10-Q. Alimera Sciences, Inc., and its subsidiaries (we or Alimera), is a pharmaceutical company that specializes in the commercialization and development of prescription ophthalmic pharma...

DMPI: DelMar Pharmaceuticals Analysis and Research Report

2018-09-25 - Asif

Background DelMar Pharmaceuticals, Inc. is a clinical stage drug development company with a focus on the treatment of cancer. The company's mission is to benefit patients and create shareholder value by developing and commercializing anti-cancer therapies for patients whose tumors exhibit features that make them resistant to, or unlikely to respond to, currently available therapies, particularly for orphan cancer indications where patients have failed, or are unlikely to respond to, currently available therapy. DelMar Pharmaceuticals is developing VAL-083, a novel, DNA-targeting agent, for the treatment of glioblastoma multiforme (“GBM”) and potentially other solid tumors, including ovarian cancer. VAL-083 is a first-in-class, DNA-targeting chemotherapeutic that demonstrated activity against a range of tumor types in prior Phase 1 and Phase 2 clinical studies sponsored by the US National Cancer Institute (“NCI”). The company's recent research has highlighted the opportunit...

RIGL: Rigel Pharmaceuticals Analysis and Research Report

2018-09-18 - Asif

Overview Rigel Pharmaceuticals is a biotechnology company dedicated to discovering, developing and providing novel small molecule drugs that significantly improve the lives of patients with immune and hematologic disorders, cancer and rare diseases. The company's pioneering research focuses on signaling pathways that are critical to disease mechanisms. The company's first FDA-approved product is TAVALISSE™ (fostamatinib disodium hexahydrate), an oral spleen tyrosine kinase (SYK) inhibitor, for the treatment of adult patients with chronic immune thrombocytopenia who have had an insufficient response to a previous treatment. The company's current clinical programs include Phase 2 studies of fostamatinib in autoimmune hemolytic anemia and IgA nephropathy, and a Phase 1 study for its IRAK program. In addition, Rigel Pharmaceuticals has product candidates in development with partners BerGenBio AS, Daiichi Sankyo, and Aclaris Therapeutics. Since inception, Rigel Pharmaceuticals h...

Silicon Investor Message Boards

This table lists all message boards related to NSE:TECHM / TECH MAHINDRA LTD. on message board site Silicon Investor.

Techmire (TCM) turnaround/lead PE of 4! Techmire (TCM) turnaround/lead PE of 4! Techmire (TCM) turnaround/lead PE of 4!